Buy Ovaltine Malted Drink 18g Online | Carrefour Kenya

Scheduled DeliveryScheduled Delivery

Express DeliveryExpress Delivery

Scheduled DeliveryScheduled Delivery
Express DeliveryExpress Delivery
Over 50,000+ products. Minimum order of Ksh 1,000. Delivery Today 5 PM
Westlands - Nairobi
More from OVALTINE

Ovaltine Malted Drink 18g

Pack size : 18g

KES 50.00(Inc. VAT)

Out Of Stock
Sold & Delivered by Carrefour
Origin -
Switzerland
highlights
Simply mix some Oval tine with milk for a drink that is good for you and nutritious. Oval tine food drink is packed with plenty of vitamins and minerals for your everyday vitality.
Get it delivered by:
OUT OF STOCK

DESCRIPTION

This chocolate malt drink contains protein and essential vitamins and minerals. Simply mix some Oval tine with milk for a drink that is good for you and nutritious. Oval tine food drink is packed with plenty of vitamins and minerals for your everyday vitality.

Nutrition facts

Per100PortionType
Average Nutritional Value As Per 100g
Per100Energyinkcal
400kcal
Per100EnergyinkJ
1673.6kJ
Per100Protein
10g
Per100Carbohydrates
80g
Per100Sugar
40g
Per100Fat
2.5g
Per100Fibre
5g
Per100Sodium
325mg
Sub Type
Malted Drink
Form
Powder
Category
Food

*Your daily values may be higher or lower depending on your calaries needs

INFORMATION

Ingredients

Barley Malt Extract (73%) Milk Serum Concentrate Fat Reduced Cocoa Powder (8%) Minerals (Calcium Magnesium Iron Zinc) Sugar Rapeseed Oil Vitamins (C E Niacin A Pantothenic Acid B12 B6 B2 B1 Folic Acid Biotin).

Storage Condition

Store In Cool And Dry Place.

Preparation and usage

Ready to drink.

Brand Message

Oval tine is a brand of milk flavouring product made with malt extract (except in the blue packaging in the united states), sugar, and whey. Some flavours also have cocoa. Oval tine, a registered trademark of associated British foods, is made by wander AG, a subsidiary of twining's, which acquired the brand from Novartis in 2002, except in the united states, where Nestle acquired the rights separately from Novartis in the late 2000s.

BACK TO TOP